Authors: Gouldson, P Legoux, P Carillon, C Delpech, B Le Fur, G Ferrara, P Shire, D

Citation: P. Gouldson et al., The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK1 receptor (vol 400, pg 185, 2000), EUR J PHARM, 407(3), 2000, pp. 333-333

Authors: Gouldson, P Calandra, B Legoux, P Kerneis, A Rinaldi-Carmona, M Barth, F Le Fur, G Ferrara, P Shire, D

Citation: P. Gouldson et al., Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB2 receptor, EUR J PHARM, 401(1), 2000, pp. 17-25

Authors: Gouldson, P Legoux, P Carillon, C Delpech, B Le Fur, G Ferrara, P Shire, D

Citation: P. Gouldson et al., The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK1 receptor, EUR J PHARM, 400(2-3), 2000, pp. 185-194

Authors: Gouldson, P Legoux, P Carillon, C Dumont, X Le Fur, G Ferrara, P Shire, D

Citation: P. Gouldson et al., Essential role of extracellular charged residues of the human CCK1 receptor for interactions with SR 146131, SR 27897 and CCK-8S, EUR J PHARM, 389(2-3), 2000, pp. 115-124

Authors: Shire, D Legoux, P

Citation: D. Shire et P. Legoux, Gene expression analysis using quantitative reverse transcription-polymerase chain reaction and a multispecific internal control, METH MOL B, 137, 2000, pp. 59-73

Authors: Gouldson, P Legoux, P Carillon, C Delpech, B Le Fur, G Ferrara, P Shire, D

Citation: P. Gouldson et al., Contrasting roles of Leu(356) in the human CCK1 receptor for antagonist SR27897 and agonist SR 146131 binding, EUR J PHARM, 383(3), 1999, pp. 339-346